US Patent Issued to SIGILON THERAPEUTICS on June 16 for "Compositions, devices and methods for inducing immune responses to infectious agents" (Massachusetts, Illinois Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,888, issued on June 16, was assigned to SIGILON THERAPEUTICS INC. (Cambridge, Mass.).

"Compositions, devices and methods for inducing immune responses to infectious agents" was invented by Hozefa Bandukwala (Southborough, Mass.), David E. Moller (Newton, Mass.) and David Peritt (Skokie, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are implantable devices comprising cells engineered to express and secrete antigens of infectious agents. The devices are useful for inducing protective immune responses against infectious agents."

The patent was filed on May 4, 2021, under Application No. 17/923,283.

*For further information, inc...